Detalhe da pesquisa
1.
Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study.
Ann Hematol
; 97(12): 2455-2463, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178193
2.
Patient- and Caregiver-Reported Burden of Transfusion-Dependent ß-Thalassemia Measured Using a Digital Application.
Patient
; 14(2): 197-208, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123986
3.
Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study.
Adv Ther
; 36(4): 870-879, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847777
4.
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.
Melanoma Res
; 28(4): 333-340, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750751
5.
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison.
Adv Ther
; 34(2): 495-512, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28000169
6.
Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma.
Adv Ther
; 33(4): 643-57, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26979173